ATL 1102 failed an in in vivo leukemia study in mice. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678723/
CD49d promotes disease progression in chronic lymphocytic leukemia, page-4
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $90.15M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $177.5K | 1.730M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 136159 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 233891 | 3 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |